行情

NVCR

NVCR

Novocure
NASDAQ

实时行情|Nasdaq Last Sale

87.29
-4.41
-4.81%
盘后: 87.20 -0.09 -0.10% 19:49 01/24 EST
开盘
92.22
昨收
91.70
最高
92.58
最低
87.03
成交量
103.72万
成交额
--
52周最高
98.84
52周最低
41.51
市值
86.37亿
市盈率(TTM)
-299.6567
分时
5日
1月
3月
1年
5年

分析师评级

7位分析师的综合评级

买入

免责声明:分析师观点仅供投资者决策参考,不构成任何买卖投资建议。

EPS

NVCR 新闻

  • 贝索斯手机遭入侵 手机窃听再次成为焦点
  • 新浪科技.4小时前
  • 知名创始人Leila Janah因癌症去世 年仅37岁
  • 新浪财经综合.4小时前
  • 苹果公司因专利侵权被判支付WiLan8500万美元专利费
  • 新浪财经综合.5小时前
  • 悉尼公布确诊病例航班信息 澳政府承诺给予免费治疗
  • 界面.5小时前

更多

所属板块

医疗设备、用品及经销
-0.74%
医疗设备和用品
-0.90%

热门股票

名称
价格
涨跌幅

NVCR 简况

NovoCure Limited is a commercial-stage oncology company. The Company is engaged in developing a cancer treatment centered on a therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Its TTFields delivery system is used for the treatment of glioblastoma (GBM) and to advance programs testing of TTFields in multiple solid tumor indications through its clinical pipeline. In addition to its clinical and commercial progress in GBM, it is planning or conducting clinical trials evaluating the use of TTFields in brain metastases, non-small-cell lung cancer (NSCLC), pancreatic cancer, ovarian cancer and mesothelioma. TTFields are delivered through a portable, medical device. The complete delivery system, which is designed to allow patients to go about their daily activities while receiving continuous cancer treatment, includes a portable electric field generator, transducer arrays, rechargeable batteries and accessories.
展开

Webull提供Novocure Ltd的股票价格,实时市场报价,专业分析师评级,深度图表和免费的股票新闻,以帮助您做出投资决策。